XWELL Inc (XWEL)
1.80
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.80
0.00 (0.00%)
After-Hours: 20:00
XWELL Cash from Investing (Quarterly): 6.822M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.822M |
September 30, 2023 | 2.598M |
June 30, 2023 | -0.48M |
March 31, 2023 | -3.29M |
December 31, 2022 | -23.91M |
September 30, 2022 | -1.731M |
June 30, 2022 | -2.419M |
March 31, 2022 | -6.779M |
December 31, 2021 | -2.784M |
September 30, 2021 | 0.282M |
June 30, 2021 | -1.668M |
March 31, 2021 | -0.986M |
December 31, 2020 | -0.87M |
September 30, 2020 | -2.134M |
June 30, 2020 | -0.761M |
March 31, 2020 | -0.584M |
December 31, 2019 | -0.634M |
September 30, 2019 | -0.839M |
June 30, 2019 | -0.227M |
March 31, 2019 | -0.575M |
December 31, 2018 | -0.091M |
September 30, 2018 | -0.69M |
June 30, 2018 | -0.891M |
March 31, 2018 | -0.194M |
December 31, 2017 | -2.507M |
Date | Value |
---|---|
September 30, 2017 | -1.109M |
June 30, 2017 | -0.847M |
March 31, 2017 | -0.933M |
December 31, 2016 | 3.45M |
September 30, 2016 | -1.826M |
June 30, 2016 | 0.763M |
March 31, 2016 | 1.087M |
December 31, 2015 | 0.168M |
September 30, 2015 | 0.015M |
June 30, 2015 | -0.009M |
March 31, 2015 | -0.278M |
December 31, 2014 | -0.10M |
September 30, 2014 | -0.101M |
June 30, 2014 | -2.377M |
March 31, 2014 | -0.072M |
December 31, 2013 | -0.944M |
September 30, 2013 | 2.451M |
June 30, 2013 | -0.003M |
March 31, 2013 | -3.14M |
December 31, 2012 | -0.057M |
September 30, 2012 | -19.41M |
June 30, 2012 | -0.006M |
March 31, 2012 | -0.005M |
December 31, 2011 | 0.025M |
September 30, 2011 | 1.028M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-23.91M
Minimum
Dec 2022
6.822M
Maximum
Dec 2023
-2.126M
Average
-0.87M
Median
Dec 2020
Cash from Investing (Quarterly) Benchmarks
Fonar Corp | -0.289M |
ProPhase Labs Inc | 2.435M |
Applied DNA Sciences Inc | -0.0148M |
Veracyte Inc | 2.878M |
OncoCyte Corp | -0.024M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -3.201M |
Free Cash Flow | -18.45M |
Free Cash Flow Per Share (Quarterly) | -0.8276 |
Free Cash Flow to Equity (Quarterly) | -3.467M |
Free Cash Flow to Firm (Quarterly) | -3.467M |
Free Cash Flow Yield | -253.9% |